A California judge said Thursday he'll grant Sorrento Therapeutics' request to scrap billionaire bioscientist and businessman Dr. Patrick Soon-Shiong's cross-claims over a $90 million transaction involving Sorrento's cancer drug, but allowed leave to amend, noting that since "half of this case went to arbitration," the judge didn't know if the claims were barred by collateral estoppel.